NCT00813527 - Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels | Biotech Hunter

Enrollment

213

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Hyperlipidemias

Interventions

DRUG

Lapaquistat acetate and fenofibrate

Lapaquistat acetate 100 mg, tablets, orally, once daily and fenofibrate 145 mg, tablets, orally, once daily for up to 12 weeks.

DRUG

Fenofibrate

Lapaquistat acetate placebo-matching tablets, orally, once daily and fenofibrate 145 mg, tablets, orally, once daily for up to 12 weeks.

Trial Locations (36)

Unknown

Huntsville

Sierra Vista

Beverly Hills

Long Beach

Spring Valley

Colorado Springs

Golden

Waterbury

Jacksonville

Kissimmee

Miami

Ocala

Pembroke Pines

Pinellas Park

West Palm Beach

Warner Robins

Chicago

Peoria

Indianapolis

Wichita

Edina

St Louis

Raleigh

Winston-Salem

Cincinnati

Columbus

Hillsboro

Beaver

Goose Creek

Nashville

Norfolk

Richmond

Coquitlam

Victoria

London

Toronto